Achuthan Sourianarayanane is a Gastroenterology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 55 publications with 706 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Division Of Gastroenterology
Milwaukee, WI 532263522
Telephone
414-955-6830Registry record last updated 5 Feb 2016.
Clinical trials
- Assessment of Fatty Liver With Thermo-acoustic Device
Sponsor: Medical College of Wisconsin
- Diagnosis of Fatty Liver With Outpatient Ultrasound
Sponsor: Medical College of Wisconsin
- Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
52.8%Aldosterone antagonist (MRA)19.2%Eplerenone50%Spironolactone50%Part D<11 patientsBeta blocker15.2%Carvedilol100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
47.2%Rifamycin Antibacterial34.4%Xifaxan100%Part D<11 patientsBile Acid12.8%Ursodiol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Liver Tissue and Plasma Ceramide Variations in Metabolic Dysfunction‐Associated Steatotic Liver Disease Based on the Number of Ceramide Carbon Atoms
European Journal of Lipid Science and Technology
2025 - Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis
PROTEOMICS - CLINICAL APPLICATIONS
2024 - Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity
Clinics and Research in Hepatology and Gastroenterology
2024 - Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients
European Journal of Gastroenterology & Hepatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”